Protection of mouse small bowel allografts by FTY720 and costimulation blockade

Transplantation

Volumn 79, Issue 12, 2005, Pages 1703-1710

  Yan, Sheng ^a,b   Rodriguez Barbosa, Jose Ignacio ^b,c   Pabst, Oliver ^b   Beckmann, Jan H ^b   Brinkmann, Volker ^d   Förster, Reinhold ^b   Hoffmann, Matthias W ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

FTY720; Mice; MR1; T lymphocytes; Transplantation

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; FINGOLIMOD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOFLUORESCENCE TEST; INTESTINE GRAFT; LAMINA PROPRIA; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; SCORING SYSTEM;

ANIMALS; ANTIBODIES, MONOCLONAL; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; LYMPHOCYTES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PROPYLENE GLYCOLS; SPHINGOSINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 21244481314     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000164501.65352.39     Document Type: Article

References (29)

1. Newell KA, Fishbein TM. Experimental models of small bowel transplantation. Curr Opin Organ Transplant 2003; 209.
2. Chueh SJ, Kahan BD. Update on FTY720: review of mechanisms and clinical results. Curr Opin Organ Transplant 2003; 8: 288.
3. Matloubian M, Lo CG, Cinamon Q, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004; 427: 355.
4. Graler MH, Goetz, EJ. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. Faseb J 2004; 18: 551.
5. Brinkmann V, Pinschewer DD, Feng L, et al. FTY. 720: altered lymphocyte traffic results in allograft protection. Transplantation 2001; 72: 764.
6. Furukawa H, Suzuki T, Jin MW, et al. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. Transplantation 2000; 69: 235.
7. Suzuki S, Kakefuda T, Amemiya H, et al. An immunosuppressive regimen using FTY720 combined with cyclosporin in canine kidney transplantation. Transpl Int 1998; 11: 95.
8. Schuurman HJ, Menninger K, Audet M, et al. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD. Transplantation 2002; 74: 951.
9. Dragun D, Fritsche L, Boehler T, et al. FTY720: early clinical experience. Transpl Proc 2004; 36: 544S.
10. Kimura T, Hasegawa T, Nakai T, et al. FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells. Transplantation 2003; 75: 1469.
11. Honey K, Cobbold SP, Waldmann H. CD. 40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol 1999; 163; 4805.
12. Elster EA, Xu H, Tadaki DK, et al. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 2001; 72: 1473.
13. Guo Z, Meng L, Kim O, et al. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 2001; 71: 1351.
14. Zhong R, Zhang Z, Quan D, et al. Intestinal transplantation in the mouse. Transplantation 1993; 56: 1034.
15. He G, Hart J, Thistlethwaite JR Jr, et al. Modified surgical model of paratopic small bowel transplantation in mice. J Surg Res 1998; 80: 188.
16. Wu T, Abu-Elmagd K, Bond G, et al. A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003; 75: 1241.
17. Pabst O, Herbrand H, Worbs T, et al. Cryptopatches and isolated lymphoid follicles: dynamic lymphoid tissues dispensable for the generation of intraepithelial lymphocytes. Eur J Immunol 2005; 35: 98.
18. Newell KA. Transplantation of the intestine: is it truly different? Am J Transplant 2003; 3: 1.
19. Guo Z, Wang J, Dong Y, et al. Long-term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion. Am J Transplant 2003; 3: 1091.
20. Konishi K, Inobe M, Yamada A, Murakami, et al. Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model. J Heart Lung Transplant 2002; 21: 692.
21. Bai Y, Liu J, Wang Y, et al. L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance. J Immunol 2002; 168: 1579.
22. Zhou P, Hwang KW, Palucki D, et al. Secondary lymphoid organs are important but not absolutely required for allograft responses. Am J Transplant 2003; 3: 259.
23. Mitsusada M, Suzuki S, Kobayashi E, et al. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation. Transpl Int 1997; 10: 343.
24. Wang ME, Tejpal N, Qu X, et al. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Transplantation 1998; 65: 899.
25. Zheng XX, Markees TG, Hancock WW, et al. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol 1999; 162: 4983.
26. Zhang L, Zhu T, Sun EW, et al. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft. Transplant Proc 2003; 35: 567.
27. Kahan BD. FTY720: a new immunosuppressive agent with novel mechanism(s) of action. Transplant Proc 1998; 30: 2210.
28. Fu F, Hu S, Deleo J, et al. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720. Transplantation 2002; 73: 1425.
29. Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 2003; 4: 154.